Trial Profile
Effective Surveillance and Impact of HPV Vaccination on Screening for Cervical Cancer in Tuscany
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 27 Nov 2014 New trial record